Simultaneous determination of pyridostigmine bromide, N,N-diethyl-m-toluamide, permethrin, and their metabolites in rat plasma and urine by high-performance liquid chromatography

被引:15
作者
Abu-Qare, AW [1 ]
Abou-Donia, MB [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2000年 / 749卷 / 02期
关键词
pyridostigmine bromide; N; N-diethyl-m-toluamide; permethrin;
D O I
10.1016/S0378-4347(00)00407-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid and simple method was developed for the separation and quantification of the anti nerve agent drug pyridostignmine bromide (PB; 3-dimethylaminocarbonyloxy-N-methyl pyridinium bromide) its metabolite N-methyl-3-hydroxypyridinium bromide, the insect repellent DEET (N,N-diethyl-m-toluamide), its metabolites m-toluamide and m-toluic acid, the insecticide permethrin (3-(2,2-dichloro-ethenyl)-2,2-dimethylcyclopropanecarboxylic acid(3-phenoxyphenyl) methylester), and two of its metabolites m-phenoxybenzyl alcohol, and m-phenoxybenzoic acid in rat plasma and urine. The method is based on using C-18 Sep-Pak(R) cartridges for solid-phase extraction (SPE) and high-performance liquid chromatography (HPLC) with reversed-phase C-18 column, and gradient UV detection ranging between 208 and 230 nm. The compounds were separated using gradient of 1 to 99% acetonitrile in water (pH 3.20) at a flow-rate ranging between 0.5 and 1.7 ml/min in a period of 17 min. The retention times ranged from 5.7 to 14.5 min. The limits of detection were ranged between 20 and 100 ng/ml, while limits of quantitation were 150-200 ng/ml. Average percentage recovery of five spiked plasma samples were 51.4+/-10.6, 71.1+/-11.0, 82.3+/-6.7, 60.4+/-11.8, 63.6+/-10.1, 69.3+/-8.5, 68.3+/-12.0, 82.6+/-8.1, and from urine 55.9+/-9.8, 60.3+/-7.4, 77.9+/-9.1, 61.7+/-13.5, 68.6+/-8.9, 62.0+/-9.5, 72.9+/-9.1, and 72.1+/-8.0, for pyridostigmine bromide, DEET, permethrin, N-methyl-3-hydroxypyridinium bromide, m-toluamide, m-toluic acid, m-phenoxybenzyl alcohol and m-phenoxybenzoic acid, respectively. The relationship between peak areas and concentration was linear over the range between 100 and 5000 ng/ml. This method was applied to analyze the above chemicals and metabolites following their administration in rats. (C) 2000 Elsevier Science BN. All rights reserved.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 42 条
[1]   Neurotoxicity resulting from coexposure to pyridostigmine bromide, DEET, and permethrin: Implications of Gulf War chemical exposures [J].
AbouDonia, MB ;
Wilmarth, KR ;
Jensen, KF ;
Oehme, FW ;
Kurt, TL .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1996, 48 (01) :35-56
[2]   Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos [J].
AbouDonia, MB ;
Wilmarth, KR ;
AbdelRahman, AA ;
Jensen, KF ;
Oehme, FW ;
Kurt, TL .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1996, 34 (02) :201-222
[3]   TOXICOKINETICS OF PERMETHRIN IN THE RAT [J].
ANADON, A ;
MARTINEZLARRANAGA, MR ;
DIAZ, MJ ;
BRINGAS, P .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 110 (01) :1-8
[4]   Determination of metabolites of pyrethroids in human urine using solid-phase extraction and gas chromatography mass spectrometry [J].
Angerer, J ;
Ritter, A .
JOURNAL OF CHROMATOGRAPHY B, 1997, 695 (02) :217-226
[5]   PHARMACOKINETICS AND ORAL BIOAVAILABILITY OF PYRIDOSTIGMINE IN MAN [J].
AQUILONIUS, SM ;
ECKERNAS, SA ;
HARTVIG, P ;
LINDSTROM, B ;
OSTERMAN, PO .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 18 (05) :423-428
[6]   CLINICAL PHARMACOKINETICS OF CHOLINESTERASE-INHIBITORS [J].
AQUILONIUS, SM ;
HARTVIG, P .
CLINICAL PHARMACOKINETICS, 1986, 11 (03) :236-249
[7]   PLASMA CLEARANCE OF NEOSTIGMINE AND PYRIDOSTIGMINE IN DOG [J].
BAKER, PR ;
CALVEY, TN ;
CHAN, K ;
MACNEE, CM ;
TAYLOR, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1978, 63 (03) :509-512
[8]   PHARMACOKINETICS OF PYRIDOSTIGMINE AND 3-HYDROXY-N-METHYLPYRIDINIUM IN RAT - DOSE-DEPENDENT EFFECTS AFTER PORTAL-VEIN ADMINISTRATION [J].
BARBER, HE ;
BOURNE, GR ;
CALVEY, TN ;
MUIR, KT .
BRITISH JOURNAL OF PHARMACOLOGY, 1975, 55 (03) :335-341
[9]   EXCRETION AND METABOLISM OF [14C]-PYRIDOSTIGMINE IN RAT [J].
BIRTLEY, RDN ;
ROBERTS, JB ;
THOMAS, BH ;
WILSON, A .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1966, 26 (02) :393-&
[10]   QUANTITATIVE GAS-LIQUID-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF NEOSTIGMINE AND PYRIDOSTIGMINE IN HUMAN-PLASMA [J].
CHAN, K ;
WILLIAMS, NE ;
BATY, JD ;
CALVEY, TN .
JOURNAL OF CHROMATOGRAPHY, 1976, 120 (02) :349-358